Adjusted for diabetes duration, patients with optimal glycemic control had a lower insulin dose compared to patients with suboptimal HbA1c (0.76 ± 0.31 U/kg/d vs. 0.87 ± 0.29 U/kg/d, respectively, p < 0.001). This evidence concerns the gene INS and diabetes mellitus.